Navigation Links
Mach One Executes Definitive Agreement to Acquire Biopharmaceutical Design & Engineering Firm
Date:2/11/2009

BELGIUM, WI, Feb. 11 /PRNewswire-FirstCall/ -- Mach One Corporation (Pink Sheets: MNCN), a global health company that develops biotechnology based solutions that produce positive, long term benefit to the agricultural and consumer markets, announced today that it has executed its definitive agreement to acquire Modular Process Constructors LLC.

The purchase price of $500,000 in the form of Convertible Preferred Stock with a conversion price of .50 per share will allow Mach One to bring in house the engineering and design experience needed to roll out its capacity expansion on a national basis -- plans that include up to 17 facilities nationally. Bringing needed in-house expertise along with the ability to engineer and design systems for world class customers, Mach One takes an important step in building their internal expertise for organic growth.

Monte B. Tobin, Chairman and Chief Executive Officer of Mach One, said, "We welcome the expertise to facilitate expansion of our business model internally combined with key engineering experts who are able to work externally with world class customers in the biopharmaceutical industry."

"This is yet another major building block Mach One is leveraging to advance our business plan through our new director, Tad M. Ballantyne. Tad joined the board with our recent acquisition of Pacific Rim Foods Ltd. and is also Managing Director of the parent company of Modular Process Constructors LLC. Through these key associations, Mr. Ballantyne has provided both capital and technology to Mach One in the execution of our business model. It's important to see that our acquisition strategy is accretive to our core business by the addition of not only revenues and assets, but of highly specialized knowledge and expertise," added Tobin.

About Mach One Corporation:

Mach One Corporation (www.machonecorp.com
'/>"/>

SOURCE Mach One Corporation
Copyright©2009 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2

Related biology technology :

1. Powersafe Technology Corp. Recapitalizes, Executes Merger Agreement with Amplification Technologies, and Invests in Amplification
2. Diamyd Strengthens Financial Position and Executes a Fully Subscribed Direct Placement
3. Rosetta Genomics Executes Binding Term Sheet to Acquire U.S. CLIA-Certified Lab to Expedite Commercialization of Diagnostic Tests
4. New Edition of Definitive Resource in Tissue Engineering Released Today
5. Arrow International Files and Mails Definitive Proxy Materials
6. IsoTis Files Definitive Proxy Statement
7. Acorn Acquisition Corp Announces Definitive Agreement to Acquire Lumen Medical Inc.
8. Elbit Medical Imaging Ltd. Announces Definitive Agreements for a Large Scale Luxury Mixed Use Project in Bangalore, India
9. Nabi Biopharmaceuticals Announces Mailing of Definitive Proxy Statement and Release Date of Third Quarter 2007 Financial Results
10. Advanced Life Sciences Enters Into Definitive Securities Purchase Agreements for $20 Million with New and Existing Institutional Investors
11. Bayer HealthCare Affiliate MEDRAD and Possis Medical Sign Definitive Merger Agreement

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:11/25/2009)...STON,Nov.25/PRNewswire/--BiotechfirmReplikinsLtd.,...8pandemicthroughtheprediction,outbreak,andprogress...emicalanalysisofthevirus.Thenewdatashowsthatthelet...eakof3.7(s.d.4.5)duringthevirus,scurrentoutbreakin...of2.0(s.d.0.1).TheH1N1virus,infectivitycount,howev...
(Date:11/25/2009)...WYORK,Nov.25/PRNewswire/--Reportlinker.comannounce...ogue: ,, BrazilBioethanolMarketAnalysisandFore...165503/Brazil-Bioethanol-Market-Analysis-and-Forec...lysisandForecaststo2013 ,, Summary ,, Ther...albioethanolmarketandtheBrazilbioethanolmarketinpa...
(Date:11/24/2009)... The New York investment bank KTA C...U) has agreed an AU$6.7 mil convertible note priva...he private placement was arranged by KTA Capital a... , New York (PRWEB) Novemb... bank KTA Capital, LLC ("KTA Capital") h...
(Date:11/24/2009)... Health care employment grew by 2...nly one to show consistent growth during the U.S. ...s remain in trouble, and health systems are coming...l, instead of just administrators. , ...re employment continued growing in October despite...
Breaking Biology Technology:Biological H1N1 Vaccines: Too Little, Too Late 2Biological H1N1 Vaccines: Too Little, Too Late 3Biological H1N1 Vaccines: Too Little, Too Late 4Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 2Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 3Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 4Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 5Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 6Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 7Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 8Reportlinker Adds Brazil Bioethanol Market Analysis and Forecasts to 2013 9KTA Capital Arranges an AU$6.7 Million Private Placement by Neuren Pharmaceuticals 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 2The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 3The MedZilla Report for October 2009 - Health Care Employment Grows Again in October Even As Clinics, Specialty Centers Close 4
...edical Systems, Growing Network of Medical Technol...Year of Profitability in 2007., PLEASANTON, Calif...an office in Russia to open a distribution network...lted in the registration of DMS,s,InNovaSound USB ... medical,providers in Russia., (Logo: http://www...
..., Calif., May 16 Immunosyn,Corporation (OTC Bulle...tained exclusive worldwide marketing, sales and di... from its affiliate Argyll Biotechnologies,LLC, ha...ch 31, 2008., For the quarter ended March 31, 200... administrative expenses and $13,393.00 in interes...
..., Calif., May 16 InterMune, Inc.,(Nasdaq: ITMN )...esident and,Chief Financial Officer of InterMune, ...re Conference in New York on May 22, 2008 at 1:30 ...presentation, investors and other,interested parti...terMune,s,corporate website at http://www.intermu...
Other Biology Technology:Direct Medical Systems Reaches Profitability in 2-1/2 Years, as a Result of Sales of the World's Smallest and Lightest Ultrasound System, the InNovaSound USB Ultrasound. 2Immunosyn Corporation Files 10-Q 2Immunosyn Corporation Files 10-Q 3
(Date:11/24/2009)...held secrets of the earth,s history locked in its ...y little information on the environments that have...years. Now, a team of researchers from nine instit...e of $10 million dollars by the National Science F... literally. These scientists will drill through th...
(Date:11/23/2009)...ociated strain of the deadly superbug MRSAan infec...ibioticsposes a far greater health threat than pre..., according to a study in the December issue of E...is easily picked up in fitness centers, schools, a...ll burden of MRSA within hospitals, the report fou...
(Date:11/23/2009)...ggests that a common oral bacterium may exacerbate...s et al, "Unique Lipids from a Common Human Bacter...of Enhancing Autoimmunity," appears in the Decembe... . , Multiple sclerosis (MS), a disease where th... affects nearly 1 in 700 people in the United Stat...
Breaking Biology News(10 mins):LSU gets to the bottom of things -- in Antarctica 2New study finds MRSA on the rise in hospital outpatients 2Factors from common human bacteria may trigger multiple sclerosis 2Retailers NGOs and Food and Beverage Industry Launch National Initiative to Help Reduce Obesity 58861 1Retailers NGOs and Food and Beverage Industry Launch National Initiative to Help Reduce Obesity 58861 2Retailers NGOs and Food and Beverage Industry Launch National Initiative to Help Reduce Obesity 58861 3Retailers NGOs and Food and Beverage Industry Launch National Initiative to Help Reduce Obesity 58861 4Transdel Pharmaceuticals to Host Conference Call and Webcast on Tuesday October 6 2009 to Announce Top Line Phase 3 Study Results for Lead Topical P 14353 1Transdel Pharmaceuticals to Host Conference Call and Webcast on Tuesday October 6 2009 to Announce Top Line Phase 3 Study Results for Lead Topical P 14353 2Transdel Pharmaceuticals to Host Conference Call and Webcast on Tuesday October 6 2009 to Announce Top Line Phase 3 Study Results for Lead Topical P 14353 3Regado Biosciences To Present at the 2009 Japan Biopharma Partnering Conference on October 6 2009 14348 1Regado Biosciences To Present at the 2009 Japan Biopharma Partnering Conference on October 6 2009 14348 2
...more than half of children with sore throat, excee...used nonrecommended antibiotics for 27 percent of ...according to a study in the November 9 issue of JA...ounts for 6 percent of visits by children to famil... to background information in the article. The mos...
...e have demonstrated that Langerhans cells in the s...stem to pathogens, instead dampen the skin,s react...potential to significantly alter understanding of ... as psoriasis, lupus and skin cancer. , Dendriti...emely efficient at alerting the immune system to t...
...iated with an increased risk of hypertension in wo...nsumption of sugared or diet colas, according to a...ately 50 million people in the United States have ...cording to background information in the article. ...eart disease, stroke, and congestive heart failure...
Other Biology News:Children overprescribed antibiotics for sore throat 2Langerhans cells regulate immune reactions in the skin 2No link found between caffeine intake and development of hypertension in women 2
Hae III (High Concentration) from Takara Mirus Bio
Sma I (High Concentration) from Takara Mirus Bio
2 ml SmartScan Racks from ABgene
Mouse Anti-beta-III-Tubulin Monoclonal Antibody, Unconjugated, Clone TU-20 from BioVendor Laboratory Medicine, Inc.
Biology Products: